Hosted on MSN3mon
Fasenra shows benefit in acute asthma and COPD in Phase II trial
A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD) has ...
Medical Marketing & Media6d
AstraZeneca takes to the pickleball court for Fasenra campaign
AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma treatment Fasenra.
Fierce Pharma11d
AstraZeneca embraces pickleball trend with Fasenra tour sponsorship, themed DTC ad
AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. | ...
pharmaphorum4d
FDA says no to AZ's Fasenra for nasal polyp indication
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
pharmaphorum5y
AZ's Fasenra also works in rare organ damage diseases
AstraZeneca’s asthma drug Fasenra also works in a group of rare diseases that can lead to potentially fatal organ damage, a mid-stage trial has shown. Results of the phase 2 trial, published in ...